Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
167
-
Total 13F shares, excl. options
-
37M
-
Shares change
-
+1.44M
-
Total reported value, excl. options
-
$700M
-
Value change
-
+$18.8M
-
Put/Call ratio
-
0.56
-
Number of buys
-
75
-
Number of sells
-
-86
-
Price
-
$18.91
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q1 2023
198 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 167 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37M shares
of 51.1M outstanding shares and own 72.35% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.04M shares), VANGUARD GROUP INC (4.32M shares), JPMORGAN CHASE & CO (4.01M shares), STATE STREET CORP (2.58M shares), Redmile Group, LLC (1.64M shares), DIMENSIONAL FUND ADVISORS LP (1.54M shares), Aquilo Capital Management, LLC (831K shares), GEODE CAPITAL MANAGEMENT, LLC (761K shares), CITADEL ADVISORS LLC (743K shares), and MILLENNIUM MANAGEMENT LLC (719K shares).
This table shows the top 167 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.